AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

MICROSAIC SYSTEMS PLC

Pre-Annual General Meeting Information Apr 21, 2017

7786_agm-r_2017-04-21_430d69f8-f217-4022-a959-80194cf6d9ee.html

Pre-Annual General Meeting Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9183C

Microsaic Systems plc

21 April 2017

21 April 2017

Microsaic Systems plc

("Microsaic", "Microsaic Systems" or the "Company")

Notice of Annual General Meeting and Posting of Annual Report

Microsaic Systems plc (AIM: MSYS), the developer of chip-based mass spectrometry instruments, announces that its Annual General Meeting ("AGM") will be held at 11:00 a.m. on 15 May 2017 at the offices of Citigate Dewe Rogerson, 3 London Wall Buildings, London, EC2M 5SY. The Annual Report (including the Notice of AGM) and the Form of Proxy will be posted to shareholders today. The Annual Report is available on the Company's website at http://www.microsaic.com/documents-announcements/.

Enquiries:
Microsaic Systems plc

Jim Ramage, CEO

Bevan Metcalf, FD
+44 (0) 1483 751577
N+1 Singer (Nominated Adviser & Broker)

Shaun Dobson

Liz Yong
+44 (0)20 7496 3000
Citigate Dewe Rogerson (Financial PR)

Mark Swallow

Marine Perrier
+44 (0)20 7282 2948/1068

About Microsaic Systems

Microsaic Systems plc is a high technology company developing chip-based, bench-top mass spectrometry ("MS") instruments that are designed to improve the efficiency of Pharma R&D. MS is an analytical technique of choice for biochemists across many industry sectors.

Microsaic aims to bring routine MS analysis to the pharmaceutical scientist, providing powerful methods of analysis to enable earlier decision making relating to product identification, purity and bioactivity.

The Company is working with established global companies in preparative and purification science with expertise in Pharma and life sciences to co-develop new, integrated and optimised, application-specific, solutions to improve productivity in the development of small molecule and novel biologic (peptides, antibodies) medicines.

The Microsaic 4000 MiD®, single quadrupole, is the world's smallest MS system, retaining the functionality of larger conventional MS systems, is easier to use by non-specialists, consumes less energy and has lower running costs. The Company is also developing new MS systems, based on its patented chip technologies, to address further areas of emerging need in Pharma R&D.

Microsaic Systems was established in 2001 by a team including founders from Imperial College London, and was admitted to AIM in 2011 (ticker: MSYS).

www.microsaic.com 

This information is provided by RNS

The company news service from the London Stock Exchange

END

NOAIMMFTMBITBJR

Talk to a Data Expert

Have a question? We'll get back to you promptly.